Ragheb Hasan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ragheb Hasan has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Douglas G. Fraser
Cardiology Department, Manchester Foundation Trust and Manchester University, Manchester Royal Infirmary, Manchester, United Kingdom
2 shared publications A Argyriou
University of Manchester , Manchester, United Kingdom
1 shared publicationA J Levine
1 shared publicationA J Ritchie
1 shared publicationA R J Cale
1 shared publication- Abdulaziz Alkhulaifi
Department of Thoracic and Cardiovascular Surgery, Heart Hospital, Hamad Medical Corporation, Doha 3050, Qatar
1 shared publication
Latest Publications
- Open Access
- 20 April 2022
- Published by Elsevier in JACC: Case Reports
- Vol. 4 (8) , 473-475
Chest Pain Post-Transcatheter Aortic Valve Implantation
- 20 April 2022
- Published by Elsevier in JACC: Case Reports
- Vol. 4 (8) , 473-475
Open AccessChest Pain Post-Transcatheter Aortic Valve Implantation
- Open Access
- 1 May 2021
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (Supplement)
302 Is Age Just A Number in Cardiac Surgery? Evaluating Outcomes of An Octogenarian Cohort at A Single Cardiac Centre
Introduction: Cardiac surgery in octogenarians contains many age-specific perioperative risk factors and outcomes yet to be fully understood. Method: All adults (N = 4957) undergoing cardiac surgery between 2011-2017 at our institution were retrospectively studied, encompassing 312 octogenarians. Data was evaluated with univariate and multivariate testing and mortality with Kaplan-Meier and cox-regression analyses. Results: Compared to septuagenarians, octogenarians revealed more patients having previous surgery (p = 0.016), less diabetic patients (p = 0.034), lower BMI (0.002), and longer hospital stay (p < 0.000). Compared to rest of study, octogenarians contained more females (p = 0.012), a greater Euroscore (p < 0.000), spent longer in ITU (p = 0.001) and contained more ITU readmissions (p = 0.023). The octogenarians did not contain significant 30- and 90-day mortality but revealed significant mortality at 1-year versus septuagenarians (p = 0.039) and rest of study (p = 0.001). Variables testing significant in a multivariate regression were inserted into a cox-regression that found octogenarian group-membership to be insignificant (p = 0.051) in a 12-covariate model. Independent risk factors for mortality included emergency surgery (p = 0.04), reoperation (p < 0.000), cardiac procedure (p = 0.007), ITU time (p = 0.041) and diabetes (p = 0.023). Conclusions: We report specific differences for octogenarians in perioperative characteristics along with promising short- and medium-term survival. Such outcomes must constantly be monitored so that cardiac surgery can be further tailored to this elderly cohort.
- 1 May 2021
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (Supplement)
Open Access302 Is Age Just A Number in Cardiac Surgery? Evaluating Outcomes of An Octogenarian Cohort at A Single Cardiac Centre
Introduction: Cardiac surgery in octogenarians contains many age-specific perioperative risk factors and outcomes yet to be fully understood. Method: All adults (N = 4957) undergoing cardiac surgery between 2011-2017 at our institution were retrospectively studied, encompassing 312 octogenarians. Data was evaluated with univariate and multivariate testing and mortality with Kaplan-Meier and cox-regression analyses. Results: Compared to septuagenarians, octogenarians revealed more patients having previous surgery (p = 0.016), less diabetic patients (p = 0.034), lower BMI (0.002), and longer hospital stay (p < 0.000). Compared to rest of study, octogenarians contained more females (p = 0.012), a greater Euroscore (p < 0.000), spent longer in ITU (p = 0.001) and contained more ITU readmissions (p = 0.023). The octogenarians did not contain significant 30- and 90-day mortality but revealed significant mortality at 1-year versus septuagenarians (p = 0.039) and rest of study (p = 0.001). Variables testing significant in a multivariate regression were inserted into a cox-regression that found octogenarian group-membership to be insignificant (p = 0.051) in a 12-covariate model. Independent risk factors for mortality included emergency surgery (p = 0.04), reoperation (p < 0.000), cardiac procedure (p = 0.007), ITU time (p = 0.041) and diabetes (p = 0.023). Conclusions: We report specific differences for octogenarians in perioperative characteristics along with promising short- and medium-term survival. Such outcomes must constantly be monitored so that cardiac surgery can be further tailored to this elderly cohort.
- Open Access
- 31 March 2017
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 12 (1) , 21
Erratum to: Is pre-operative haemoglobin A1c level a successful predictor of adverse outcome after cardiac surgery?
- 31 March 2017
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 12 (1) , 21
Open AccessErratum to: Is pre-operative haemoglobin A1c level a successful predictor of adverse outcome after cardiac surgery?
- 17 November 2015
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 31, 207.e1-207.e3
Pseudoaneurysm of the Right Internal Mammary Artery Post Vacuum-Assisted Closure Therapy: A Rare Complication and Literature Review
- 17 November 2015
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 31, 207.e1-207.e3
Pseudoaneurysm of the Right Internal Mammary Artery Post Vacuum-Assisted Closure Therapy: A Rare Complication and Literature Review
- Open Access
- 22 October 2015
- Published by BMJ in Open Heart
- Vol. 2 (1) , e000170
Does the CHA2DS2-Vasc score predict procedural and short-term outcomes in patients undergoing transcatheter aortic valve implantation?
Background: Transcatheter aortic valve implantation (TAVI) is associated with periprocedural and postprocedural morbidity and mortality. Currently, there is a paucity of risk stratification models for potential TAVI candidates. We employed the CHA2DS2-Vasc score to quantify the risk of 30-day mortality and morbidity in patients undergoing TAVI. Methods and results: A retrospective analysis of registry data for consecutive patients undergoing TAVI at 3 tertiary centres in Northwest England between 2008 and 2013. The CHA2DS2-Vasc score and its modification—the R2CHA2DS2-Vasc score, which includes pre-existing renal impairment and pre-existing conduction abnormality (right bundle branch block/left bundle branch block, RBBB/LBBB)—were calculated for all patients. A total of 313 patients with a mean age of 80 (79.1–80.8) years underwent TAVI. The implanted devices were either the CoreValve or the Edwards-SAPIEN prosthesis. The 30-day mortality was 14.3% in those with a CHA2DS2-Vasc score ≥6, whereas it was only 6.2% in those with a score 2-CHA2DS2-Vasc score, the difference was more pronounced with a 30-day mortality of 22.6% in those patients with an R2-CHA2DS2-Vasc score ≥7 compared to 6.0% in those with a R2-CHA2DS2-Vasc score 2DS2-Vasc score (hazard ratio (HR)= 2.71, (1.01 to 7.31); p2CHA2DS2-Vasc score (HR=4.27 (1.51 to 12.07); p=0.006) with 30-day mortality. Conclusions: Our study demonstrates the potential use of the CHA2DS2-Vasc or the R2CHA2DS2-Vasc score to quantify the risk of mortality in patients undergoing TAVI. This could have significant implications in terms of clinical as well as patients’ decision-making.
- 22 October 2015
- Published by BMJ in Open Heart
- Vol. 2 (1) , e000170
Open AccessDoes the CHA2DS2-Vasc score predict procedural and short-term outcomes in patients undergoing transcatheter aortic valve implantation?
Background: Transcatheter aortic valve implantation (TAVI) is associated with periprocedural and postprocedural morbidity and mortality. Currently, there is a paucity of risk stratification models for potential TAVI candidates. We employed the CHA2DS2-Vasc score to quantify the risk of 30-day mortality and morbidity in patients undergoing TAVI. Methods and results: A retrospective analysis of registry data for consecutive patients undergoing TAVI at 3 tertiary centres in Northwest England between 2008 and 2013. The CHA2DS2-Vasc score and its modification—the R2CHA2DS2-Vasc score, which includes pre-existing renal impairment and pre-existing conduction abnormality (right bundle branch block/left bundle branch block, RBBB/LBBB)—were calculated for all patients. A total of 313 patients with a mean age of 80 (79.1–80.8) years underwent TAVI. The implanted devices were either the CoreValve or the Edwards-SAPIEN prosthesis. The 30-day mortality was 14.3% in those with a CHA2DS2-Vasc score ≥6, whereas it was only 6.2% in those with a score 2-CHA2DS2-Vasc score, the difference was more pronounced with a 30-day mortality of 22.6% in those patients with an R2-CHA2DS2-Vasc score ≥7 compared to 6.0% in those with a R2-CHA2DS2-Vasc score 2DS2-Vasc score (hazard ratio (HR)= 2.71, (1.01 to 7.31); p2CHA2DS2-Vasc score (HR=4.27 (1.51 to 12.07); p=0.006) with 30-day mortality. Conclusions: Our study demonstrates the potential use of the CHA2DS2-Vasc or the R2CHA2DS2-Vasc score to quantify the risk of mortality in patients undergoing TAVI. This could have significant implications in terms of clinical as well as patients’ decision-making.
- 1 June 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 174 (2) , e77-e78
Percutaneous tricuspid valve-in-valve implantation in Ebstein's anomaly: One-year follow-up of valve function
- 1 June 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 174 (2) , e77-e78
Percutaneous tricuspid valve-in-valve implantation in Ebstein's anomaly: One-year follow-up of valve function